Increased risk of disseminated cryptococcal infection in a patient with multiple sclerosis on fingolimod
Sign Up to like & getrecommendations! Published in 2020 at "IDCases"
DOI: 10.1016/j.idcr.2020.e00961
Abstract: Multiple sclerosis (MS) is the most common autoimmune disease of the central nervous system (CNS), with an estimated 2.3 million people being affected globally, and is a major cause of permanent disability. About 90 %… read more here.
Keywords: disseminated cryptococcal; multiple sclerosis; increased risk; fingolimod ... See more keywords
A fatal disseminated cryptococcal infection in a patient treated with zanubrutinib for Waldenström’s macroglobulinemia
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/10781552221087730
Abstract: Introduction Zanubrutinib is a second generation, irreversible small-molecule Bruton tyrosine kinase inhibitor (BTK) approved for the treatment of Waldenström's macroglobulinemia, mantle cell lymphoma, and marginal zone lymphoma. As a class, BTKs have been linked with… read more here.
Keywords: waldenstr macroglobulinemia; cryptococcal infection; disseminated cryptococcal; patient ... See more keywords